Effect of Continuous Glucose Monitoring Following Hospital Discharge of Patients With Type 2 Diabetes
Initiating CGM at hospital discharge was feasible, safe, and associated with significant glycemic improvement at 12 weeks. Additional studies are needed to optimize the implementation of CGM following discharge.
Authors
- Eileen R. Faulds (ORCID: https://orcid.org/0000-0003-2315-1146)
- Kathleen Marie Dungan (ORCID: https://orcid.org/0000-0003-1289-1595)
- Sara Yi Ling Folk (ORCID: https://orcid.org/0009-0009-3426-5289)
- Kathleen Wyne (ORCID: https://orcid.org/0000-0003-4118-8727)
- Elizabeth Buschur (ORCID: https://orcid.org/0000-0001-6818-8925)
- Cara Harris (ORCID: https://orcid.org/0000-0002-6148-7719)
- Jianing Ma (ORCID: https://orcid.org/0009-0001-3621-8744)
- TREVOR SOBOL
- THAINA GATTI
- Cecilia Wallace
- Melanie Natasha Rayan (ORCID: https://orcid.org/0009-0005-0646-5508)
- Philicia Duncan
Institutions
- The Ohio State University Wexner Medical Center (US)
- The Ohio State University (US)
Publication Details
- Journal
- Journal of the Endocrine Society
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1210/jendso/bvaf169
- Citations
- 1
- Primary Topic
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- Eli Lilly and Company
- Sanofi
- Insulet Corporation
- Dexcom